1 Agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
21 Cardiovascular agents
|
211 Cardiotonics
|
212 Antiarrhythmic agents
|
2121 Procainamides
|
2122 Quinidines
|
2123 Beta blockers
|
2129 Others
|
D00303 Disopyramide (JP18/USAN/INN)
D00637 Disopyramide phosphate (JAN/USP)
D02086 Lidocaine hydrochloride (JAN/USP)
D00639 Mexiletine hydrochloride (JP18/USP)
D01326 Aprindine hydrochloride (JP18/USAN)
D00640 Propafenone hydrochloride (JP18/USP)
D00638 Flecainide acetate (JP18/USP)
D00636 Amiodarone hydrochloride (JP18/USP)
D01455 Cifenline succinate (USAN); Cibenzoline succinate (JP18)
D01026 Sotalol hydrochloride (JAN/USP)
D00619 Verapamil hydrochloride (JP18/USP)
D00631 Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN)
D01554 Pilsicainide hydrochloride hydrate (JP18)
D01785 Pirmenol hydrochloride hydrate (JAN)
D01856 Nifekalant hydrochloride (JAN)
|
213 Diuretics
|
214 Antihypertensives
|
215 Capillary stabilizers
|
216 Vasoconstrictors
|
217 Vasodilators
|
218 Hyperlipidemia agents
|
219 Miscellaneous
|
22 Respiratory organ agents
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
26 Epidermides
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|